The incidence of rebleeding in traumatic hyphema.
A collaborative, retrospective study of 371 consecutive hyphema patients reveals an overall 3.5% incidence of rebleeding of without the use of antifibrinolytic agents. Numerous factors were reviewed on each patient, including age, sex, race, grade of hyphema, disposition, and the use of topical or systemic medications. Thirty percent of the patients were treated on an outpatient basis. The low incidence of rebleeding, particularly in less severe hyphemas (less than half the anterior chamber volume), does not support the routine use of systemic antifibrinolytics or corticosteroids.
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000367:Age Factors; D000368:Aged; D000704:Analysis of Variance; D001241:Aspirin / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D005131:Eye Injuries / Q000150:complications*; D005260:Female; D006801:Humans; D006988:Hyphema / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology*; D007223:Infant; D008297:Male; D008875:Middle Aged; D009184:Mydriatics / Q000627:therapeutic use; D012008:Recurrence; D014949:Wounds, Nonpenetrating / Q000150:complications*
D000305:Adrenal Cortex Hormones; D009184:Mydriatics; D001241:Aspirin